Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature
Main Authors: | Linch, Stefanie, Kasiewicz, Melissa J, McNamara, Michael, Hilgart, Ian, Farhad, Mohammad, Redmond, William |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649323/ |
Similar Items
-
Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T cell anergy and promotes survival in tumor-bearing mice
by: Linch, Stefanie, et al.
Published: (2015) -
Biomarkers of survival statistics (boss) analytical platform
by: McNamara, Michael, et al.
Published: (2015) -
Common gamma chain (γc) cytokines differentially potentiate TNFR family signaling in antigen-activated CD8+ T cells
by: McNamara, Michael J, et al.
Published: (2014) -
Murine peripheral blood prognostic biomarkers for tumor survival following combination aCTLA-4 and aPD-1 treatment
by: Hilgart-Martiszus, Ian, et al.
Published: (2015) -
Combination OX40 agonism/CTLA-4 blockade with vaccination reverses anergy and primes tumor-specific CD8 T cells in mice with spontaneous prostate cancer
by: Linch, Stefanie N, et al.
Published: (2013)